
1. lancet haematol. 2015 oct;2(10):e437-44. doi: 10.1016/s2352-3026(15)00152-0. epub
2015 sep 22.

glucose-6-phosphate dehydrogenase deficiency risk malaria other
diseases children kenya: case-control cohort study.

uyoga s(1), ndila cm(2), macharia aw(1), nyutu g(1), shah s(3), peshu n(1),
clarke gm(4), kwiatkowski dp(5), rockett ka(4), williams tn(6); malariagen
consortium.

collaborators: vanderwal a, elzein a, nyika a, mendy a, miles a, diss a,
kerasidou a, green a, jeffreys ae, macinnis b, hughes c, moyes c, spencer cc,
hubbart c, malangone c, potter c, mead d, barnwell d, kwiatkowski dp, jyothi d,
drury e, somaskantharajah e, hilton e, leffler e, maslen g, band g, busby g,
clarke gm, ragoussis i, garcia ja, rogers j, devries j, shelton j, ragoussis j,
stalker j, o'brien j, evans j, rowlands k, cook k, fitzpatrick k, kivinen k,
small k, johnson kj, rockett ka, hart l, manske m, mccreight m, stevens m,
pirinen m, hennsman m, parker m, sanjoaquin m, sepúlveda n, cook o, miotto o,
deloukas p, craik r, wrigley r, watson r, pearson r, hutton r, auburn s, shah s, 
le sq, molloy s, bull s, campino s, clark tg, ruano-rubio v, cornelius v, teo yy,
corran p, de silva n, risley p, doyle a, evans j, horstmann r, plowe c, duffy p, 
carucci d, gottleib m, tall a, ly ab, dolo a, sakuntabhai a, puijalon o, bah a,
camara a, sadiq a, khan aa, jobarteh a, mendy a, ebonyi a, danso b, taal b,
casals-pascual c, conway dj, onykwelu e, sisay-joof f, sirugo g, kanyi h, njie h,
obu h, saine h, sambou i, abubakar i, njie j, fullah j, jaiteh j, bojang ka,
jammeh k, sabally-ceesay k, manneh l, camara l, yamoah l, njie m, njie m, pinder 
m, jallow m, aiyegbo m, jasseh m, keita ml, saidy-khan m, jallow m, ceesay n,
rasheed o, ceesay pl, esangbedo p, cole-ceesay r, olaosebikan r, correa s, njie
s, usen s, dibba y, barry a, djimde a, sall ah, abathina a, niangaly a, dembele
a, poudiougou b, diarra e, bamba k, thera ma, doumbo o, toure o, konate s,
sissoko s, diakite m, konate at, modiano d, bougouma ec, bancone g, ouedraogo in,
simpore j, sirima sb, mangano vd, troye-blomberg m, oduro ar, hodgson av, ghansah
a, nkrumah f, atuguba f, koram ka, amenga-etego ln, wilson md, ansah na, mensah
n, ansah pa, anyorigiya t, asoala v, rogers wo, akoto ao, ofori ao, enimil a,
ansong d, sambian d, asafo-agyei e, sylverken j, antwi s, agbenyega t, orimadegun
ae, amodu fa, oni o, omotade oo, amodu o, olaniyan s, ndi a, yafi c, achidi ea,
mbunwe e, anchang-kimbi j, mugri r, besingi r, apinjoh to, titanji v, elhassan a,
hussein a, mohamed h, elhassan i, ibrahim m, kokwaro g, oluoch t, macharia a,
ndila cm, newton c, opi dh, kamuya d, bauni e, marsh k, peshu n, molyneux s,
uyoga s, williams tn, marsh v, manjurano a, nadjm b, maxwell c, drakeley c, riley
e, mtei f, mtove g, wangai h, reyburn h, joseph s, ishengoma d, lemnge m,
mutabingwa t, makani j, cox s, phiri a, munthali a, kachala d, njiragoma l,
molyneux me, moore m, ntunthama n, pensulo p, taylor t, nyirongo v, carter r,
fernando d, karunaweera n, dewasurendra r, suriyaphol p, singhasivanon p, simmons
cp, thai cq, sinh dx, farrar j, van chuong l, phu nh, hieu nt, mai nt, quyen nt, 
day n, dunstan sj, o'riordan se, chau tt, hien tt, allen a, lin e, karunajeewa h,
mueller i, reeder j, manning l, laman m, michon p, siba p, allen s, davis tm.

author information: 
(1)department epidemiology demography, kemri-wellcome trust research
programme, kilifi, kenya.
(2)department epidemiology demography, kemri-wellcome trust research
programme, kilifi, kenya; wellcome trust centre human genetics, university of
oxford, oxford, uk.
(3)wellcome trust centre human genetics, university oxford, oxford, uk;
laboratory malaria vector research, national institute allergy and
infectious diseases, national institutes health, bethesda, md, usa.
(4)wellcome trust centre human genetics, university oxford, oxford, uk.
(5)wellcome trust centre human genetics, university oxford, oxford, uk;
wellcome trust sanger institute, hinxton, cambridge, uk.
(6)department epidemiology demography, kemri-wellcome trust research
programme, kilifi, kenya; department medicine, imperial college, st mary's
hospital, london, uk. electronic address: tom.williams@imperial.ac.uk.

comment in
    lancet haematol. 2015 oct;2(10):e400-1.

background: global prevalence x-linked glucose-6-phosphate dehydrogenase
(g6pd) deficiency thought result selection malaria, but
epidemiological studies yielded confusing results. investigated the
relationships g6pd deficiency malaria non-malarial illnesses
among children kenya.
methods: study kilifi county, kenya, g6pd c.202t allele 
is significant cause g6pd deficiency. tested associations
between g6pd deficiency severe complicated plasmodium falciparum malaria 
through case-control study 2220 case 3940 control children. cases were
children aged younger 14 years, visited high dependency ward of
kilifi county hospital severe malaria march 1, 1998, feb 28,
2010. controls children aged 3-12 months born within the
same study area august 2006, september 2010. assessed the
association g6pd deficiency uncomplicated malaria other
common diseases childhood cohort study 752 children aged younger 
10 years. participants study recruited representative sample 
of households within ngerenya chonyi areas kilifi county aug
1, 1998, july 31, 2001. primary outcome measure case-control
study odds ratio hospital admission severe malaria (computed 
logistic regression) cohort study incidence rate ratio
for uncomplicated malaria non-malaria illnesses (computed poisson
regression), g6pd deficiency category.
findings: 2863 (73%) children control group versus 1643 (74%) case 
group g6pd normal genotype, 639 (16%) versus 306 (14%) girls
heterozygous g6pd c.202t, 438 (11%) versus 271 (12%) children either
homozygous girls hemizygous boys. compared boys girls without g6pd
deficiency, found significant protection severe malaria (odds ratio [or] 
0·82, 95% ci 0·70-0·97; p=0·020) among g6pd c.202t heterozygous girls no
evidence protection among g6pd c.202t hemizygous boys homozygous girls
(or 1·18, 0·99-1·40; p=0·056). median follow-up mild disease cohort study
was 2·24 years (iqr 2·22-2·85). g6pd c.202t effect common
diseases childhood heterozygous girls (incidence rate ratio 0·98, 95% ci
0·86-1·11; p=0·82) homozygous girls hemizygous boys (0·93, 0·82-1·04;
p=0·25), sole exception marginally significant increase the
incidence helminth infections among heterozygous girls.
interpretation: heterozygous girls might driving force positive
selection g6pd deficiency alleles. studies needed definitively 
establish mechanisms g6pd deficiency confers advantage against
malaria heterozygous individuals. studies could lead development
of new treatments.
funding: wellcome trust, uk medical research council, european union, and
foundation national institutes health (as part bill & melinda
gates grand challenges global health initiative).

copyright © 2015 uyoga et al. open access article distributed terms 
cc by. published elsevier ltd.. rights reserved.

doi: 10.1016/s2352-3026(15)00152-0 
pmcid: pmc4703047
pmid: 26686045  [indexed medline]

